KRT5 and breast carcinoma: In addition, Reid et al. developed a 3D HCI platform to identify inhibitors of cytokeratin 5 (CK5), a biomarker of breast cancer cells, by quantifying changes in the expression level of CK5 promoter-enhanced green fluorescent protein (CK5Pro-GFP) with intensity sum and area parameters [74].